article · In Silico Research in Biomedicine
This study highlights an extensive computational inquiry of the solvent effect on the chemical properties of a newly synthesized 1-(4-Chlorophenyl)-3-(3,5-dimethylphenyl)-5-(3-fluorophenyl)-4H-1,2,4-triazol-4yl) urea (CDF-TU) . The study aims to examine the effects of solvents on the chemical properties and lead compound potentials of compound CDF-TU against Chlamydia trachomatis . Density functional theory at the B3LYP-D3(BJ)/aug-cc-evqz level of theory was used for the study of the electronic effect of the compound (CDF-TU) in ethanol, water, and gas. This study examined the pharmacokinetic attributes of CDF-TU, confirming its alignment with Lipinski's rule, and other parameters such as molecular weight of 435.88 g/mol. Moreover, the HOMO-LUMO analysis revealed the ionization energies of CDF-TU showed that water had more stabilizing effect on the compound with the highest energy gap of 5.2543 eV. Also, CDF-TU in water had the highest electronegativity of 3.9136eV compared to Ethanol (3.8884eV) and gas (3.2068eV). Molecular docking analysis revealed that, compared with doxycycline, the standard drug, CDF-TU had higher binding affinity (-8.9 Kcal/mol) compared to Doxycycline (-7.8 Kcal/mol) with protein 1RCW when surrounded by water molecules. Hence, CDF-TU records a lower inhibition (0.298µM) constant when compared to Doxycycline (1.876µM). However, in the absence of water, CDF-TU records the same magnitude of binding affinity with Doxycycline (-6.3 Kcal/mol). More hydrogen bonds were formed with CDF-TU and protein 1RCW in water compared to the compound's interaction with protein 1RCW without water. However, these findings demonstrate the biological potential of CDF-TU due to its docking performance amidst the presence of water.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.insi.2026.100294
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.